Prevalence of chronic kidney disease in the United States.

@article{Coresh2007PrevalenceOC,
  title={Prevalence of chronic kidney disease in the United States.},
  author={Josef Coresh and Elizabeth Selvin and Lesley A. Stevens and Jane Manzi and John W. Kusek and Paul Eggers and Frederick van Lente and Andrew S. Levey},
  journal={JAMA},
  year={2007},
  volume={298 17},
  pages={
          2038-47
        }
}
CONTEXT The prevalence and incidence of kidney failure treated by dialysis and transplantation in the United States have increased from 1988 to 2004. Whether there have been changes in the prevalence of earlier stages of chronic kidney disease (CKD) during this period is uncertain. OBJECTIVE To update the estimated prevalence of CKD in the United States. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional analysis of the most recent National Health and Nutrition Examination Surveys (NHANES… 
Trends in Prevalence of Chronic Kidney Disease in the United States.
TLDR
In a reversal of prior trends, there has been no appreciable increase in the prevalence of stage 3 and 4 CKD in the U.S. population overall during the most recent decade.
Determining prevalence of chronic kidney disease using estimated glomerular filtration rate.
TLDR
There is some concern about the absolute percentage of patients with stage 3 CKD, defined as estimated glomerular filtration rate (GFR) between 30 and 59 mL/min/1.73 m, which could be overestimated, due to the use of the Modification of Diet in Renal Disease (MDRD) Study formula with a resultant systematic GFR underestimation.
Temporal trends in the burden of chronic kidney disease in the United States
  • R. Foley
  • Medicine
    Current opinion in nephrology and hypertension
  • 2010
TLDR
Given its prevalence and prognostic implications, it makes intuitive sense to monitor the burden of CKD over time; the validity of the tools used to generate an answer is at least as important as the direction of the answer.
Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
  • J. Snyder, R. Foley, A. Collins
  • Medicine
    American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2009
TLDR
Although CKD prevalence is high regardless of varying modeling assumptions, different assumptions yield large differences in prevalence estimates.
Recent trends in the prevalence of chronic kidney disease: not the same old song
Purpose of review We aim to review recent updates on the epidemiology of chronic kidney disease (CKD). Recent findings Recent analyses from the National Health and Nutritional Examination survey
Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey
TLDR
The prevalence of kidney dysfunction was substantial in the survey population, including individuals without hypertension or diabetes, conditions most likely to prompt screening for kidney dysfunction, and highlights the potential for missed opportunities for early intervention and secondary prevention of chronic kidney disease.
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
  • M. Grams, S. Juraschek, +5 authors J. Coresh
  • Medicine
    American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2013
TLDR
The prevalence of reduced eGFRcys in the US civilian noninstitutionalized population increased between 1988-1994 and 1999-2002, confirming the increase observed in the prevalence of reducing eG FRcr.
Prevalence of chronic kidney disease in the Japanese general population
TLDR
The prevalence of CKD stages 1, 2, 3, and 4 + 5 were 0.6, 1.7, 10.7 and 0.2% in the study population, which resulted in predictions of 0.3% of the Japanese adult population—approximately 13.3 million people—were predicted to have CKD in 2005.
Temporal trends in the prevalence of diabetic kidney disease in the United States.
TLDR
Prevalence of DKD in the United States increased from 1988 to 2008 in proportion to the prevalence of diabetes, and was stable despite increased use of glucose-lowering medications and renin-angiotensin-aldosterone system inhibitors among persons with diabetes.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 42 REFERENCES
Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.
TLDR
Overall CKD prevalence was similar in both surveys (9% using ACR > 30 mg/g for persistent microalbuminuria; 11% in 1988 to 1994 and 12% in 1999 to 2000 using gender-specific ACR cutoffs) and awareness in the U.S. population is low.
Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004.
TLDR
The results underscore the need to continue surveillance for CKD and its risk factors in the United States and to implement new strategies to reduce the number of persons with this condition.
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
TLDR
CKD is common and warrants improved detection and classification using standardized criteria to improve outcomes, and CCr estimates showed a steeper decline with age and were lower in non-Hispanic blacks.
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization.
TLDR
The data suggest that efforts to reduce mortality in this population should be focused on treatment and prevention of coronary artery disease, congestive heart failure, diabetes mellitus, and anemia.
Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.
TLDR
The key to understanding black-white differences in ESRD incidence lies in understanding the extreme differences in their progression from CRI to ESRd.
Evaluation of the modification of diet in renal disease study equation in a large diverse population.
TLDR
The MDRD Study equation provides unbiased and reasonably accurate estimates across a wide range of subgroups when eGFR is <60 ml/min per 1.73 m(2), and in individual patients, interpretation of GFR estimates should be interpreted with caution to avoid misclassification of chronic kidney disease in the context of the clinical setting.
Secular trends in cardiovascular disease risk factors according to body mass index in US adults.
TLDR
Except for diabetes, CVD risk factors have declined considerably over the past 40 years in all BMI groups, and although obese persons still have higher risk factor levels than lean persons, the levels are much lower than in previous decades.
Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000
TLDR
In a multiple regression analysis, increasing age, increasing body mass index, and non-Hispanic black race/ethnicity were independently associated with increased rates of hypertension.
Projecting the number of patients with end-stage renal disease in the United States to the year 2015.
TLDR
A Markov model developed to predict ESRD incidence, prevalence, and mortality to the year 2015 is discussed, incorporating expected changes in age/race distributions, diabetes prevalence, ESRd incidence, and probability of death.
Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease
TLDR
This cross-sectional study compared GFR estimated by the MDRD equation with GFR measured by iothalamate clearance in 320 patients with chronic kidney disease and 580 healthy kidney donor candidates, and developed a new GFR prediction equation based on both healthy persons and patients with Chronic kidney disease.
...
1
2
3
4
5
...